Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04455893 · ClinicalTrials.gov registry record · NA

Don't Throw Your Heart Away: Clinician Study 3

A NA study, sponsored by Carnegie Mellon University.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT04455893 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04455893, a NA study, has completed, sponsored by Carnegie Mellon University.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

Publicly available outcome assessments for transplant programs do not make salient that some programs tend to reject many of the hearts they are offered, whereas other programs accept a broader range of donor offers. The investigators use empirical studies to test whether transplant center performance data (i.e. transplant and waitlist outcome statistics) that reflect center donor acceptance rates influence laypersons to evaluate centers with high organ decline rates less favorably than centers with low organ decline rates. 125 heart transplant clinical personnel will be recruited from International Heart and Lung Society (ISHLT) and the Pediatric Heart Transplant Society (PHTS) and randomized to one of two different information presentation conditions. Participants will be asked to view the table of transplant outcomes corresponding to the condition they were randomized to. Each participant is asked to choose the hospital that they would consider to be "higher-performing" between two hospitals: one hospital with a non-selective, "accepting" strategy (takes all donor heart offers), and one hospital with a more selective, "cherrypicking" strategy (tends to reject donor offers that are less than "excellent" quality).

Interventions

  • OTHER Stratified Transplant Survival

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2020-06-30
Est. Completion 2020-10-31
Phase NA

Sponsor

Carnegie Mellon University

37 total trials

What the Registry Record Tells You About NCT04455893

The ClinicalTrials.gov registry entry for NCT04455893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stratified Transplant Survival is the first listed.

NCT04455893 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04455893 about?

NCT04455893 is a clinical study titled "Don't Throw Your Heart Away: Clinician Study 3". Publicly available outcome assessments for transplant programs do not make salient that some programs tend to reject many of the hearts they are offered, whereas other programs accept a broader range of donor offers. The investigators use empirical studies to test whether transplant center performan...

What is the current status of trial NCT04455893?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2020-06-30. Estimated completion is 2020-10-31.

What interventions are being tested in trial NCT04455893?

The interventions under investigation include: Stratified Transplant Survival (OTHER).

Who is sponsoring clinical trial NCT04455893?

This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.